Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically used for cancer that is HER2 receptor positive. It may be used by itself or together with other chemotherapy medication
Herceptin works by attaching itself to the HER2 receptors on the surface of breast cancer cells and blocking them from receiving growth signals. By blocking the signals, Herceptin can slow or stop the growth of the breast cancer. Herceptin is an example of an immune targeted therapy.
Find The FDA Herceptin Package Insert in PDF below
[pdf-embedder url=”https://www.publichealth.com.ng/wp-content/uploads/2021/01/Herceptin-Package-Insert.pdf” title=”Herceptin Package Insert”]
